Gabriel N. Contreras

机构：University of Miami

发表论文 161 篇 · 总被引 12151 次 · h-index 50

代表论文

• Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 (2020 · JAMA Internal Medicine · 被引 561)
• Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial (2023 · The Lancet · 被引 301)
• Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial (2023 · The Lancet · 被引 226)
• A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis (2021 · Kidney International · 被引 214)
• Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19 (2021 · Annals of Internal Medicine · 被引 141)
• 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus Nephritis (2025 · Arthritis & Rheumatology · 被引 119)